HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senate HELP To Hear From Stakeholders In Changed Cosmetics Industry

This article was originally published in The Rose Sheet

Executive Summary

Since 2012 when a House committee held the last cosmetics hearing, industry generally has warmed to – or resigned itself to – legislative proposals to update the cosmetics regulatory system. However, there is still not consensus on the details among big business, SMEs and consumer advocates, all of which will be represented at the Senate HELP Committee’s witness table.

You may also be interested in...

FDA’s Candid Overview Of Cosmetics Regime Signals Support For Reform Bill

In a letter to California Democratic Senator Dianne Feinstein, FDA’s Acting Associate Commissioner for Legislation Dayle Cristinzio acknowledges the agency’s limited insight into cosmetic formulations and safety information, which makes it a struggle to respond to issues as they arise. Feinstein characterizes the letter as an admission of current system failings and a nod of support for her Personal Care Products Safety Act.

Handcrafted Cosmetics Sector Says Exemptions In Reform Bills Are Insufficient

Trade association for micro-sized cosmetics businesses says draft reform bills in the House and Senate propose exemption thresholds for registration and other requirements that are too low, failing to account for the high costs and unique challenges faced by its members.

Pallone/Lance Cosmetics Proposal Leaves Preemption Blanks To Be Filled

The New Jersey congressmen are still working on language regarding a key challenge facing cosmetics legislation. There is still no consensus among stakeholders on whether and to what extent states should be barred from imposing regulations on cosmetic companies that differ from or add to federal requirements.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts